IRCT20080901001165N50招募中3 期
Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19
Sina Darou Laboratories Company0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age: equal or more than 18 years;
- •The patient have written consciously and freely consent to participate in the study.
- •The patient's clinical symptoms (dry cough, shortness of breath, fever) confirm COVID-19.
- •Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation.
- •Less than 7 days have passed since the onset of symptoms.
排除标准
- •History of allergy to this nasal spray ingredients;
- •Hypersensitivity reaction while taking this inhaled spray;
- •The patient is in another clinical trial at the same time;
- •The patient needs to receive medical care from the intensive care unit;
研究者
相似试验
已完成
不适用
Comparison effect of Azithromycin and Amoxiclave in treatment of acute sinusitis.Sinusitis.Diseases of respiratory systemIRCT201401046252N5Shahrekord University of Medical Sciences78
已完成
不适用
Evaluation of early clinical efficacy of azithromycin SR in treatment of acute pharyngotonsillitis and acute rhinosinusitisAcute pharyngotonsillitis Acute rhinosinusitisJPRN-UMIN000004743Wakayama-Okayama Otolaryngology Pharma300
尚未招募
不适用
A retrospective study for the effects of azithromycin administration and ultrasonic scaling in patients with severe periodontitissevere periodontitisJPRN-UMIN000037439Tokyo Medical and Dental University15
招募中
不适用
The Efficacy and Safety of Azithromycin in Preventing Bronchopulmonary Dysplasia in Ureaplasma-positive Preterm InfantsCertain conditions originating in the perinatal periodKCT0002373Asan Medical Center56
已完成
3 期
The effect of azithromycin in treatment of COVID19IRCT20200415047092N1Tehran University of Medical Sciences110